Prospective Recurrent Pregnancy Loss Registry
1 other identifier
observational
3,000
1 country
1
Brief Summary
The purpose of this Registry is to prospectively collect data of Recurrent Pregnancy Loss (RPL) patients attending the specialized care centre at the BC Women's Hospital, in order to evaluate investigation practices, treatment options, and outcomes for this patient population over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 12, 2022
CompletedFirst Submitted
Initial submission to the registry
August 3, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2032
December 13, 2024
December 1, 2024
10.5 years
August 3, 2023
December 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Live Birth
Percent of patients with a live birth within 5 years after initial visit at the clinic.
5 years
Interventions
Follow-up questionnaires sent every year for the 5 years following the patient's initial visit.
Eligibility Criteria
Patients at the BC Women's Recurrent Pregnancy Loss Clinic seen for recurrent pregnancy loss.
You may qualify if:
- Patients seen at the BC Women's Recurrent Pregnancy Loss Clinic with recurrent pregnancy loss, defined as ≥2 pregnancy losses before 20 weeks of gestation.
You may not qualify if:
- Patients at BC Women's Recurrent Pregnancy Loss Clinic seen for reasons other than recurrent pregnancy loss.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BC Women's Hospital & Health Centre
Vancouver, British Columbia, V6H 3N1, Canada
Biospecimen
Products of conception (optional)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed A. Bedaiwy, MD, PhD
BC Women's Hospital & Health Centre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Professor and Head Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, University of British Columbia
Study Record Dates
First Submitted
August 3, 2023
First Posted
August 14, 2023
Study Start
July 12, 2022
Primary Completion (Estimated)
December 31, 2032
Study Completion (Estimated)
December 31, 2032
Last Updated
December 13, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share